Dopo l'orario di chiusura: 55.81

Catalent Inc. (CTLT)

Catalent Inc. Borsa (CTLT) Ultime notizie

Catalent Inc. (CTLT)

Catalent Inc. Borsa (CTLT) Ultime notizie

Catalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up

Catalent (CTLT) Reports Q3 Loss, Misses Revenue Estimates

Should You Invest in Novo Nordisk (NVO) Ahead of Q1 Earnings?

TAK or CTLT: Which Is the Better Value Stock Right Now?

Charles River (CRL) Forges Collaboration With Ship of Theseus

Beyond The Numbers: 6 Analysts Discuss Catalent Stock

Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?

Did Novo Nordisk Just Get a Jump on Eli Lilly?

Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?

Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?

Prediction: Eli Lilly and Novo Nordisk Stock Could Just be Getting Started. Here's Why

Record-High S&P 500 Propels SPY ETF To $500-Billion Milestone, Nvidia Tops $2 Trillion, Broadcom Surpasses Tesla

Top Stocks Not Named Nvidia You Need To Know About In 2024: Here's What Investors Think About Them (Wall Street Vs. Reddit)

Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors

In-Depth Examination Of 5 Analyst Recommendations For Catalent

Novo Nordisk Is Scaling a Barrier to Growth. Should You Buy Its Stock Now?

Novo Nordisk Just Gave Investors $16.5 Billion More Reasons to Get Excited

Can Financial, Healthcare, Energy Stocks Rise as Rates Stay High?

Catalent (CTLT) Q2 Earnings Lag Estimates, Gross Margin Down

Catalent (CTLT) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

US Stocks Set To Open Higher, Finish Week Stronger Amid Mixed Earnings: Analyst Sees Another Leg-Up Ahead Of Historically Weak March

The Skinny On Novo Nordisk: Weight-Loss Meds Make Big Pharma A Big Foe For Food Industry

Catalent (CTLT) Rides on Acquisition Offer From Novo Holdings

Catalent (CTLT) to Report Q2 Earnings: What's in the Cards?

Catalent Analysts Raise Their Forecasts Following Acquisition News

Uber To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday

Strength Seen in Catalent (CTLT): Can Its 9.7% Jump Turn into More Strength?

Not All Of Big Tech Posted Magnificent Results For Q4 2023

Why Catalent Stock Soared Today

Why Novo Nordisk Stock Crushed the Market on Monday

Not All of Big Tech Posted Magnificent Results for Q4

Stocks Fall As Traders Dial Back Rate Cut Bets; Dollar, Treasury Yields Rise: What's Driving Markets Monday?

Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B

Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On Monday

Novo Nordisk, struggling to meet weight-loss drug demand, to buy facilities in three-way deal

Novo Nordisk’s controlling shareholder to buy Catalent for $16.5 billion

Analyst Expectations For Catalent's Future

S&P 500 Shatters Records: The Top-Performing Stocks In January 2024

Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?

Stock Market News for Jan 8, 2024

Recursion Pharmaceuticals (RXRX) Soars 7.4%: Is Further Upside Left in the Stock?

Catalent (CTLT) Up 4.1% Since Last Earnings Report: Can It Continue?

Here's Why You Should Retain Catalent (CTLT) Stock for Now

Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

Jim Cramer: Buy This Financial Stock, 'I Think They're High Quality'

Wall Street Breakfast: What Moved Markets

Catalent (CTLT) Reports Q1 Earnings: What Key Metrics Have to Say

Catalent (CTLT) Preliminary Q1 Revenues Dampened by Lower Sales

Simile a CTLT